Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis. Braune S, Lang M, Bergmann A, NeuroTransData Study Group J Neurol. 2015 Dec 8. Epub 2015 Dec 08. PMID: 26645389. Abstract CommentRecommendBookmarkWatch